Celgene International Sarl (NASDAQ: CELG) today announced that clinical investigators from leading cancer research centers will present data from recent and on-going clinical trials evaluating Celgene products in blood cancers and solid tumors at the American Society of Clinical Oncology (ASCO) Meeting in Chicago, Illinois from June 4-8. Additionally, clinical data will be presented on Celgene products in blood cancers at the International Myeloma Working Group Summit in Barcelona, Spain from June 8-9 and the European Hematology Association annual meeting in Barcelona, Spain from June 10-13... 
More...
More...